02225.HK
Jinhai Medical Technology Limited
HKSE · Industrials · Staffing & Employment Services · HK
HKD 4.20
−6.98%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 104.9M | 46.3M | 50.2M | 45.6M | 22.3M |
| Cost of Revenue | 87.0M | 39.1M | 38.8M | 33.6M | 12.2M |
| Gross Profit | 17.9M | 7.2M | 11.5M | 12.0M | 10.1M |
| Operating Expenses | |||||
| R&D Expense | 742.0K | 742.0K | — | — | — |
| SG&A Expense | 53.2M | 25.0M | 32.0M | 16.0M | 10.3M |
| General & Admin Expense | 42.7M | 24.5M | 31.9M | 15.9M | 10.2M |
| Selling & Marketing Expense | 350.0K | 553.0K | 11.0K | 13.0K | 12.0K |
| Other Expenses | (46.5K) | 183.0K | (458.0K) | 669.0K | (560.8K) |
| Total Operating Expenses | 53.9M | 25.9M | 31.5M | 16.6M | 9.7M |
| Cost and Expenses | 140.8M | 65.0M | 70.3M | 50.2M | 21.9M |
| Operating Income (EBIT) | (35.9M) | (18.8M) | (20.0M) | (4.6M) | 268.0K |
| Non-Operating | |||||
| Interest Income | 63.8K | 7.9K | 18.0K | 56.0K | 11.0K |
| Interest Expense | 1.1M | 665.4K | 773.0K | 221.0K | 85.3K |
| Net Interest Income | (1.1M) | (657.5K) | (755.0K) | (165.0K) | (74.0K) |
| Other Non-Op Income/Expense | 3.5M | 1.6M | 1.8M | 1.4M | 516.0K |
| Non-Operating Income (excl Interest) | (742.0K) | (742.0K) | 71.0K | (1.6M) | (601.0K) |
| EBT (Pre-Tax Income) | (32.5M) | (17.2M) | (18.2M) | (3.2M) | 784.0K |
| Income Tax Expense | 887.6K | 233.0K | 28.0K | 895.0K | 668.3K |
| Bottom Line | |||||
| Net Income | (33.4M) | (17.1M) | (18.0M) | (3.1M) | 468.0K |
| Earnings from Cont. Ops | (33.4M) | (17.4M) | (18.3M) | (4.1M) | 116.0K |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (33.4M) | (17.1M) | (18.0M) | (3.1M) | 468.0K |
| Per Share | |||||
| Basic EPS | (HK$0.01) | (HK$0.00) | (HK$0.00) | (HK$0.00) | HK$0.00 |
| Diluted EPS | (HK$0.01) | (HK$0.00) | (HK$0.00) | (HK$0.00) | HK$0.00 |
| Revenue Per Share | HK$0.02 | HK$0.01 | HK$0.01 | HK$0.04 | HK$0.02 |
| Shares | |||||
| Basic Shares Outstanding | 5.3B | 5.2B | 5.2B | 1.2B | 1.2B |
| Diluted Shares Outstanding | 5.3B | 5.2B | 5.2B | 1.2B | 1.2B |
| Profitability Metrics | |||||
| EBITDA | (26.9M) | (14.4M) | (16.8M) | 1.1M | 5.3M |
| D&A | 8.3M | 3.6M | 3.3M | 4.1M | 4.4M |
| EBIT | (35.2M) | (18.0M) | (20.1M) | (3.0M) | 869.0K |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026